🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Bile acids regulating farnesoid X receptor (FXR) interact with hepatitis B ...
Status
Completed
Location
Scientia Clinical Research Limited
Start Date
2017-09-21
Trial ID
NCT03272009
Treatments Being Tested
This is a Phase 1, single-center, open-label, three subsequent dosing perio...
Status
Completed
Location
Cmax Clinical Research Pty Ltd
Start Date
2018-02-12
Trial ID
NCT03469583
Treatments Being Tested
The farnesoid X receptor (FXR) regulates hepatitis B virus replication thro...
Status
Completed
Location
PRA-EDS
Start Date
2017-02-10
Trial ID
NCT03320616
Treatments Being Tested
This is a prospective, multi-centre, randomized, double-blind, placebo-cont...
Status
Terminated
Location
ENYO PHARMA Investigative site AU02
Start Date
2020-05-12
Trial ID
NCT04465916
Treatments Being Tested
The study is designed to investigate the absorption, metabolism, and excret...
Status
Completed
Location
QPS Netherlands B.V.
Start Date
2019-07-24
Trial ID
NCT04037618
Treatments Being Tested
This is a multi centre, two parallel arm, randomized, open-label, Phase 2a ...
Status
Completed
Location
ENYO PHARMA Investigative site HK01
Start Date
2020-05-25
Trial ID
NCT04365933
Treatments Being Tested
This is a single centre, open label, randomized, 3 treatment arms, with and...
Status
Completed
Location
ENYO Pharma clinical site
Start Date
2019-06-11
Trial ID
NCT03976687
Treatments Being Tested
This study is a proof-of-concept trial of vonafexor safety, its effects on ...
Status
Completed
Location
Dr Eric Wallace - University of Alabama
Start Date
2024-08-01
Trial ID
NCT06425055
Treatments Being Tested
The farnesoid X receptor (FXR) regulates hepatitis B virus replication thro...
Status
Completed
Location
Multiple Locations
Start Date
2016-08
Trial ID
NCT03110276
The purpose of this study is to assess the effects of EYP001a (Vonafexor) w...
Status
Completed
Location
ENYO PHARMA Investigative site 0424
Start Date
2019-01-30
Trial ID
NCT03812029